Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists.

Mpox, once a rare virus mainly confined to parts of Central Africa, is rapidly evolving into a more serious global health ...

Bavarian Nordic vaccine, originally approved for smallpox, is safe and well tolerated in at-risk individuals, with one dose ...

Health officials in Karachi have confirmed the city’s first case of mpox after a 28-year-old man from Shah Latif Town tested ...

Two vaccine doses recommended for all, especially for people with HIV “We assume that people living with HIV develop protection against Mpox after the second vaccine dose, and urgently advise these ...

The NIH stopped recruiting for trials of tecovirimat against mpox after the drug was deemed not significantly more effective vs. placebo. Other antivirals against mpox are under development ...

Sierra Leone on Wednesday started injecting frontline health care workers and high-risk individuals and children from age 12 ...

Two vaccine doses recommended for all, especially for people with HIV "We assume that people living with HIV develop protection against Mpox after the second vaccine dose, and urgently advise ...

Common symptoms for Mpox include rash, fever, sore throat, headache, muscle aches, back pain, low energy, and swollen lymph nodes. Symptoms usually begin within a week but can start one to 21 days ...